Comparison of McGrath Series 5 and Airtraq Videolaryngoscope for Double-lumen Tube (DLT) Intubation

NCT02329041 | Completed DMC

• 1 other identifier: TJMZK201412002
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

Previous study showed that McGrath Series 5 videolaryngoscope is an alternative tool for double-lumen tube intubation. We have compared it with traditional Macintosh laryngoscopefor double-lumen tube intubation. In this study, we will investigate its role in double-lumen tube intubation by comparison with another videolarygoscope.

Conditions

Intubation;Difficult; Thoracic Disease; Intubation Complication

Keywords

videolaryngoscope; double-lumen tube; intubation

Outcome Measures

Primary Outcomes (1)

• Intubation time

  defined as time from inserting blade to mouth to withdrawal of blade, measured with a stopwatch

  at intubation

Secondary Outcomes (2)

• number of successful intubation at first attempt

  at intubation

• total successful rate of DLT intubation

  at intubation

Other Outcomes (1)

• Airway evaluation with Cormack-Lehane Score

  At intubation

Study Arms (2)

McGrath Series 5

EXPERIMENTAL

DLT intubation with McGrath Series 5 videolaryngoscope

Device: McGrath Series 5

Airtraq

ACTIVE COMPARATOR

DLT intubation with Airtraq videolaryngoscope

Device: Airtraq

Interventions

McGrath Series 5 DEVICE

one kind of videolaryngoscopes, which are widely used in airway management.

McGrath Series 5

Airtraq DEVICE

another kind of videolaryngoscopes, which are also widely used in airway management.

Airtraq

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adult patients
• Thoracic surgery required one lung ventilation

You may not qualify if:

• ASA physical status \>4
• Emergent operation
• planned tracheotomy
• difficult intubation predicted by a simplified airway risk index score

Sponsors & Collaborators

• Huazhong University of Science and Technology: lead

Study Sites (1)

Tongji Hospital, Huazhong University of Science and Technology

Wuhan, Hubei, 430030, China

Location

MeSH Terms

Conditions

Thoracic Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

• Yuke Tian, M.D.

  yktian@tjh.tjmu.edu.cn

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: M.D.

Study Record Dates

• First Submitted: December 21, 2014
• First Posted: December 31, 2014
• Study Start: January 1, 2015
• Primary Completion: April 1, 2016
• Study Completion: May 1, 2016
• Last Updated: April 4, 2017

Record last verified: 2017-04

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)